Blog Posts

Virginia Drug Affordability Panel Bill Heads Back to Spanberger After Legislature Rejects Amendments

Virginia Gov. Abigail Spanberger (D) will soon decide the fate of a bill that would establish provisions similar to a prescription drug affordability board.
The fate of a Virginia prescription drug affordability advisory panel is in jeopardy after the state legislature rejected Gov. Abigail [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Three Drugmakers to Refund 340B Covered Entities for Overcharges, One Announces NDC Changes

A screenshot of HRSA website
Three drugmakers recently announced refunds to 340B covered entities for overcharges, while one announced NDC changes.
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2024 and 2026, while a New [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Q: What is the primary problem 340B Referral Compass solves?

Referral Compass helps covered entities (CEs) address one of the most difficult and often underdeveloped areas…

Read More »

News Alert

Federal Judge Strikes Down North Dakota’s 340B Contract Pharmacy Access Law

U.S. District Court for the District of North Dakota.
The U.S. District Court for the District of North Dakota recently struck down the state's 340B contract pharmacy access law.
A North Dakota federal judge on Monday struck down the state’s 340B contract pharmacy access law in a sharply worded [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

News Alert

UPDATED: GOP Lawmakers Accuse Urban Hospitals of Misusing 340B Program at U.S. House Hearing

U.S. Rep. Jason Smith (R-Mo.) began the House Ways & Means Committee’s hearing by arguing that large hospital systems “manipulate the 340B drug pricing program to keep steep drug discounts for themselves instead of passing the savings to low-income patients.”
Republican members of a key U.S. House panel on Tuesday criticized some 340B urban hospitals’ use of a rural designation—accusing [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Hospital Group Again Asks HRSA to Address Drugmakers’ 340B In-House Pharmacy Claims Data Requirements

AHA again urged HRSA on Monday to address what it called “unlawful” drugmaker policies that require 340B covered entities to report 340B claims data for in-house pharmacy utilization following new reported threats from Eli Lilly.
A key hospital trade group again urged the Health Resources and Services Administration (HRSA) on Monday to address what it [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Industry Insights Logo

Navigating Contract Pharmacy Restrictions in 2026

SPONSORED CONTENT

Despite a number of state laws protecting 340B covered entities (CEs) access to contract pharmacies, lawsuits by manufacturers, court decisions, and pending appeals create significant uncertainty for these entities. These contract pharmacy restrictions can limit access to important 340B medications and

Read More »

340B Lobbying Held Steady in First Quarter of 2026, Filings Show

Screenshot of Leavitt Partners lobbying disclosure.
More than 320 firms listed the 340B program in their first quarter federal lobbying disclosure forms that were due April 20.
The 340B program continued to draw heavy lobbying attention on Capitol Hill in the first three months of 2026, as [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Indiana to Exempt Health Centers From New Policy Ending 340B Savings Under Medicaid

FSSA logo
The Indiana Family and Social Services Administration (FSSA), which oversees the state Medicaid program, is carving out FQHCs from its proposal to “fully discontinue Medicaid reimbursement” for drugs purchased under the 340B program.

Indiana will exempt community health centers from a controversial new state policy that will eliminate most providers’ ability to generate 340B savings under Medicaid managed care.

The Indiana Family and Social Services Administration (FSSA), which oversees the state Medicaid program,

Read More »

Two GOP Lawmakers Circulate Letter Supporting 340B Rebates as Eight Senate Democrats Join Effort Opposing Them

U.S. Reps. Diana Harshbarger (R-Ten.) and Earl “Buddy” Carter (R-Ga.)
U.S. Reps. Diana Harshbarger (R-Ten.) and Earl “Buddy” Carter (R-Ga.) recently asked colleagues to sign onto a letter supporting a 340B rebate model.
Two senior U.S House Republicans, who have long pushed for sweeping 340B program reforms, recently circulated a letter urging support [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live